AR and prostate carcinoma: Importantly, many ESRP-regulated exons in prostate cancer cells have reciprocal splicing patterns when prostate cancer cells were stimulated with androgens versus treatment with a drug called Casodex that is used to antagonise the androgen receptor [30].